Arrayon Biotechnology is a technology provider transporting its proprietary surface biofunctionalization technology to life science and medical markets. With our patented linker polymer family, OptoDex®, and proprietary surface functionalization technologies we cover a large scope of applications: from robust bioanalytics for in vitro diagnostics to biofunctionalization of surfaces of implants and medical devices.

Arrayon Biotechnology SA was founded in 2004 as a start-up company of CSEM, the Centre Suisse d’Electronique et de Microtechnique SA, Neuchâtel. Arrayon’s platform technology is based on solid scientific research that was carried out in the past 20 years at the University of Berne and at CSEM Neuchâtel. The technology is protected by 9 patents and patent applications.